Watson Pharmaceuticals, Inc. (NYSE:WPI)
CAPS Rating:
The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.
The #1 Community for Investors
The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
276. Watson Pharmaceuticals (NYSE: WPI) is down from $70 where it topped in 2011. At the present price of around $62, I think that there is a little upside here. Target: $63-$68. My 2012 EPS estimate is $5.60 which puts this at a P/E of 11.1 for a company growing at a double digit clip. Definately looks inexpensive here. Glad to see Bret agrees. I'll be playing CAPS points on this one.
http://beta.fool.com/bradford86/2012/01/14/price-market-part-42/